Key insights
- Jim Cramer offers his 'lightning round' stock picks, with a notable buy recommendation for Vistra, despite acknowledging it as a 'falling knife' that has pulled back. He expresses caution on Fair Isaac Corporation due to AI disruption concerns and remains positive on Clover Health Investments as a speculative long-term play. Cramer also notes a lack of expected consolidation for Stryker. While individual stock picks have limited broad market impact, Cramer's commentary can influence sentiment for specific names.
In this article
Fair Isaac Corporation: “This is a company a lot of people feel will be hurt by AI. I like the company, but I’m not going to go there because I’m not going to get in the crosshairs anymore of these companies that might get hurt by AI. It’s too painful.”
Clover Health Investments: “You could say that I was not bullish enough on it. I’m focused on how great United Health is, and how great CVS is, but yes as a spec, that one was right, but I like mine for the long haul.”
Vistra: “It went too high. It’s come back down. I’m going to bless it. [Buy, buy, buy.] It is a falling knife. I know I would only put on like 25% of my position, but it’s too low.”
Stryker: “I kept thinking that there would be consolidator and Stryker would do the consolidating...and it has not come true...I thought they would work out something, and they haven’t.”
Click here to read Jim Cramer’s Guide to Investing at no cost to help you build long-term wealth and invest smarter
Sign up now for the CNBC Investing Club to follow Jim Cramer’s every move in the market.
Disclaimer
Questions for Cramer? Call Cramer: 1-800-743-CNBC
Want to take a deep dive into Cramer’s world? Hit him up! Mad Money Twitter - Jim Cramer Twitter - Facebook - Instagram
Questions, comments, suggestions for the “Mad Money” website? madcap@cnbc.com